1. Home
  2. UBCP vs ASBPW Comparison

UBCP vs ASBPW Comparison

Compare UBCP & ASBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBCP
  • ASBPW
  • Stock Information
  • Founded
  • UBCP 1902
  • ASBPW N/A
  • Country
  • UBCP United States
  • ASBPW United States
  • Employees
  • UBCP N/A
  • ASBPW N/A
  • Industry
  • UBCP Major Banks
  • ASBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBCP Finance
  • ASBPW Health Care
  • Exchange
  • UBCP Nasdaq
  • ASBPW Nasdaq
  • Market Cap
  • UBCP N/A
  • ASBPW N/A
  • IPO Year
  • UBCP N/A
  • ASBPW 2022
  • Fundamental
  • Price
  • UBCP $13.00
  • ASBPW $0.07
  • Analyst Decision
  • UBCP
  • ASBPW
  • Analyst Count
  • UBCP 0
  • ASBPW 0
  • Target Price
  • UBCP N/A
  • ASBPW N/A
  • AVG Volume (30 Days)
  • UBCP 10.1K
  • ASBPW N/A
  • Earning Date
  • UBCP 05-08-2025
  • ASBPW N/A
  • Dividend Yield
  • UBCP 6.53%
  • ASBPW N/A
  • EPS Growth
  • UBCP N/A
  • ASBPW N/A
  • EPS
  • UBCP 1.27
  • ASBPW N/A
  • Revenue
  • UBCP $28,961,000.00
  • ASBPW N/A
  • Revenue This Year
  • UBCP N/A
  • ASBPW N/A
  • Revenue Next Year
  • UBCP $5.59
  • ASBPW N/A
  • P/E Ratio
  • UBCP $10.73
  • ASBPW N/A
  • Revenue Growth
  • UBCP N/A
  • ASBPW N/A
  • 52 Week Low
  • UBCP $11.40
  • ASBPW N/A
  • 52 Week High
  • UBCP $14.94
  • ASBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • UBCP 45.15
  • ASBPW N/A
  • Support Level
  • UBCP $12.53
  • ASBPW N/A
  • Resistance Level
  • UBCP $14.23
  • ASBPW N/A
  • Average True Range (ATR)
  • UBCP 0.60
  • ASBPW 0.00
  • MACD
  • UBCP -0.02
  • ASBPW 0.00
  • Stochastic Oscillator
  • UBCP 14.12
  • ASBPW 0.00

About ASBPW Aspire Biopharma Holdings Inc. Warrant

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.

Share on Social Networks: